Citation Impact
Citing Papers
Angiotensin II causes hypertension and cardiac hypertrophy through its receptors in the kidney
2006 StandoutNobel
Drug-Induced Reduction in Albuminuria Is Associated with Subsequent Renoprotection
2014
Liraglutide and Cardiovascular Outcomes in Type 2 Diabetes
2016 Standout
Non-invasive detection of endothelial dysfunction in children and adults at risk of atherosclerosis
1992 Standout
Acute kidney injury
2012 Standout
SGLT2 inhibitors for primary and secondary prevention of cardiovascular and renal outcomes in type 2 diabetes: a systematic review and meta-analysis of cardiovascular outcome trials
2018 Standout
Should We STOP Angiotensin Converting Enzyme Inhibitors/Angiotensin Receptor Blockers in Advanced Kidney Disease?
2016 Standout
Empagliflozin and Progression of Kidney Disease in Type 2 Diabetes
2016 Standout
Diabetic kidney disease: a clinical update from Kidney Disease: Improving Global Outcomes
2014
Safety and effectiveness of transdermal nicotine patch in smokers admitted with acute coronary syndromes
2005
European Society of Hypertension recommendations for conventional, ambulatory and home blood pressure measurement
2003
Prognostic significance of visit-to-visit variability, maximum systolic blood pressure, and episodic hypertension
2010 Standout
Safety issues in pharmacotherapy for smoking in patients with cardiovascular disease
2003
Endothelial dysfunction and inflammation in asymptomatic proteinuria
2003
Guidelines for the ultrasound assessment of endothelial-dependent flow-mediated vasodilation of the brachial artery
2002 Standout
The gut–renal axis: do incretin-based agents confer renoprotection in diabetes?
2013
Canagliflozin and renal outcomes in type 2 diabetes: results from the CANVAS Program randomised clinical trials
2018
Lixisenatide in Patients with Type 2 Diabetes and Acute Coronary Syndrome
2015 Standout
Aspirin plus Clopidogrel as Secondary Prevention after Stroke or Transient Ischemic Attack: A Systematic Review and Meta-Analysis
2014 Standout
Bardoxolone Methyl in Type 2 Diabetes and Stage 4 Chronic Kidney Disease
2013
Effect of antihypertensive treatment at different blood pressure levels in patients with diabetes mellitus: systematic review and meta-analyses
2016
The Path to an Angiotensin Receptor Antagonist-Neprilysin Inhibitor in the Treatment of Heart Failure
2015
Nitric Oxide and Peroxynitrite in Health and Disease
2007 Standout
Nicotine replacement therapy for smoking cessation
2008
Estimating Glomerular Filtration Rate from Serum Creatinine and Cystatin C
2012 Standout
Contrast-Induced Acute Kidney Injury
2016
Antioxidants and Atherosclerotic Heart Disease
1997 Standout
Sodium–glucose cotransporter-2 inhibition and the potential for renal protection in diabetic nephropathy
2014
Improving the efficacy of RAAS blockade in patients with chronic kidney disease
2012
Canagliflozin and Cardiovascular and Renal Events in Type 2 Diabetes
2017 Standout
Distinct roles for the kidney and systemic tissues in blood pressure regulation by the renin-angiotensin system
2005 StandoutNobel
Chronic kidney disease and cardiovascular risk: epidemiology, mechanisms, and prevention
2013 Standout
Combined Angiotensin Inhibition for the Treatment of Diabetic Nephropathy
2013
Design and Baseline Characteristics of the Finerenone in Reducing Kidney Failure and Disease Progression in Diabetic Kidney Disease Trial
2019
The L-Arginine-Nitric Oxide Pathway
1993 Standout
Circulating Endothelial Progenitor Cells, Vascular Function, and Cardiovascular Risk
2003 Standout
Impaired endothelial function occurs in the systemic arteries of children with homozygous homocystinuria but not in their heterozygous parents
1993
The Hallmarks of Aging
2013 Standout
Evolving importance of kidney disease: from subspecialty to global health burden
2013
The Role of Sulphonylureas in the Management of Type 2 Diabetes Mellitus
2004
The effect of RAAS blockade on the progression of diabetic nephropathy
2013
Endothelium-dependent dilation in the systemic arteries of asymptomatic subjects relates to coronary risk factors and their interaction
1994
Task Force II: Blood pressure measurement and cardiovacular outcome
2001
Blood pressure lowering for prevention of cardiovascular disease and death: a systematic review and meta-analysis
2015 Standout
Homocysteine and Atherothrombosis
1998 Standout
Prediabetes: a high-risk state for diabetes development
2012 Standout
Pre-eclampsia
2015 Standout
Effect of Finerenone on Albuminuria in Patients With Diabetic Nephropathy
2015
Kidney Disease as a Risk Factor for Development of Cardiovascular Disease
2003 Standout
Dissecting racial bias in an algorithm used to manage the health of populations
2019 StandoutScience
Nicotine replacement therapy for smoking cessation
2012 Standout
Role of Endothelial Dysfunction in Atherosclerosis
2004 Standout
Arterial Stiffness and Cardiovascular Events
2010 Standout
Chronic Kidney Disease Diagnosis and Management
2019 Standout
Type 2 diabetes: principles of pathogenesis and therapy
2005 Standout
2019 ACC/AHA Guideline on the Primary Prevention of Cardiovascular Disease: Executive Summary: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines
2019 Standout
2017 ACC/AHA/HFSA Focused Update of the 2013 ACCF/AHA Guideline for the Management of Heart Failure: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines and the Heart Failure Society of America
2017 Standout
Prevention of diabetes and reduction in major cardiovascular events in studies of subjects with prediabetes: meta-analysis of randomised controlled clinical trials
2011
Impaired nitric oxide-mediated flow-induced dilation in arterioles of spontaneously hypertensive rats.
1994
Guidelines for the Primary Prevention of Stroke
2014 Standout
Effect of Nateglinide on the Incidence of Diabetes and Cardiovascular Events
2010
Aortic Stiffness Is an Independent Predictor of All-Cause and Cardiovascular Mortality in Hypertensive Patients
2001 Standout
Quantitative Insulin Sensitivity Check Index: A Simple, Accurate Method for Assessing Insulin Sensitivity In Humans
2000 Standout
Drugs for treatment of very high blood pressure during pregnancy
2013
Impact of Aortic Stiffness on Survival in End-Stage Renal Disease
1999 Standout
Effect of Finerenone on Chronic Kidney Disease Outcomes in Type 2 Diabetes
2020 Standout
Fibrosis — A Common Pathway to Organ Injury and Failure
2015 Standout
Multicentre randomized controlled trial of angiotensin-converting enzyme inhibitor/angiotensin receptor blocker withdrawal in advanced renal disease: the STOP-ACEi trial
2015
Coronary Plaque Disruption
1995 Standout
Blood Pressure Lowering in Type 2 Diabetes
2015
Ambulatory blood pressure monitoring and 24-h blood pressure control as predictors of outcome in treated hypertensive patients
2001
The clinical effectiveness and cost-effectiveness of bupropion and nicotine replacement therapy for smoking cessation: a systematic review and economic evaluation
2002
Superoxide: a key player in hypertension
2004
Pulsatile versus steady component of blood pressure: a cross-sectional analysis and a prospective analysis on cardiovascular mortality.
1989
Dapagliflozin in Patients with Chronic Kidney Disease
2020 Standout
Dapagliflozin and Cardiovascular Outcomes in Type 2 Diabetes
2018 Standout
Nitric Oxide Is Responsible for Flow-Dependent Dilatation of Human Peripheral Conduit Arteries In Vivo
1995 Standout
Consensus Statement by the American Association of Clinical Endocrinologists and American College of Endocrinology on the Comprehensive Type 2 Diabetes Management Algorithm – 2018 Executive Summary
2018
Recommendations for Blood Pressure Measurement in Humans and Experimental Animals
2005 Standout
2019 ACC/AHA Guideline on the Primary Prevention of Cardiovascular Disease: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines
2019 Standout
Endothelial Function and Dysfunction
2007 Standout
Works of Patrick Brunel being referenced
Rationale and study design of the Prospective comparison of Angiotensin Receptor neprilysin inhibitor with Angiotensin receptor blocker MEasuring arterial sTiffness in the eldERly (PARAMETER) study
2014
Cardiorenal End Points in a Trial of Aliskiren for Type 2 Diabetes
2012
Arterial distensibility and ambulatory blood pressure monitoring in essential hypertension
1988
Mortality following a cardiovascular or renal event in patients with type 2 diabetes in the ALTITUDE trial
2015
Cardiovascular Safety of Transdermal Nicotine Patches in Patients with Coronary Artery Disease who Try to Quit Smoking
1998
Flow-dependent vasodilation of brachial artery in essential hypertension
1990
Pregnancy-Induced Hypertension Develops in Spite of Increased Plasma Concentrations of Cardionatrin
1986
[Pulse pressure and echocardiographic parameters in essential arterial hypertension].
1988
Nateglinide Improves Early Insulin Secretion and Controls Postprandial Glucose Excursions in a Prediabetic Population
2002
Comparison of Estimates of Insulin Sensitivity From Minimal Model Analysis of the Insulin-Modified Frequently Sampled Intravenous Glucose Tolerance Test and the Isoglycemic Hyperinsulinemic Clamp in Subjects With NIDDM
1995